B Akwongo, E Katuura, AM Nsubuga, P Tugume… - Tropical Medicine and …, 2022 - Springer
Background The emergence of resistant Candida species to antifungal drugs has led to resurgence in herbal usage globally. However, little is known about anti-candida plants. This …
A Subedi, MK Upreti, JC Rana, RP Sapkota… - Journal of Medical …, 2024 - Elsevier
Vulvovaginal candidiasis is a yeast infection commonly caused by the overgrowth of Candida species in and around the vulva and vagina. Abnormal vaginal discharge, itching …
R Wiench, D Paliga, A Mertas, E Bobela… - Dentistry Journal, 2024 - mdpi.com
Background: Candida albicans and similar species are significant pathogens in immunocompromised and hospitalized individuals, known for mucosal colonization and …
Vulvovaginal candidiasis is the second most common vaginal infection caused by drug- resistant Candida species that affects about 70–75% of reproductive age group women …
M Aghaei, M Kianpour, F Mardanian… - Journal of Family & …, 2023 - ncbi.nlm.nih.gov
Objective: In vitro and in vivo researches have shown that silver nanoparticles have more antimicrobial properties with a lower concentration than antifungal agents against candida …
Επί του παρόντος, η επιδημιολογική εικόνα της καντιντιασικής αιδoιοκολπίτιδας (VVC) παγκοσμίως παραμένει ασαφής. Συγχρόνως, εξακολουθούν να υπάρχουν κενά αναφορικά με …
Background: The acquired immune deficiency syndrome (AIDS), which HIV brings on, is a major public health concern. The human immunodeficiency virus (HIV) is still a pandemic …
Introduction: Vulvovaginal candidiasis (VVC) is an infection of the vaginal mucosa that extends to the vulva due to excessive growth of Candida albicans, causing a progressive …